Bioterrorism: Implications for the Clinical Microbiologist

doi:10.1128/CMR.14.2.364-381.2001

This Article

	Full Text
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager
	Reprints and Permissions
	Copyright Information
	Books from ASM Press
	MicrobeWorld

Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Klietmann, W. F.
	Articles by Ruoff, K. L.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Klietmann, W. F.
	Articles by Ruoff, K. L.

Previous Article | Next Article

Clinical Microbiology Reviews, April 2001, p. 364-381, Vol. 14, No. 2
0893-8512/01/$04.00+0 DOI: 10.1128/CMR.14.2.364-381.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Bioterrorism: Implications for the Clinical Microbiologist

Wolfgang F. Klietmann¹^,² and Kathryn L. Ruoff¹^,²^,³^,^*

Department of Pathology¹ and Clinical Microbiology Laboratories,³ Massachusetts General Hospital, Boston, Massachusetts 02114, and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115²

The specter of bioterrorism has captured the attention of government and military officials, scientists, and the general public.Compared to other sectors of the population, clinical microbiologistsare more directly impacted by concerns about bioterrorism. Thisreview focuses on the role envisioned for clinical laboratoriesin response to a bioterrorist event. The microbiology and clinicalaspects of the biological agents thought to be the most likelytools of bioterrorists are presented. The historical backgroundof the problem of bioterrorism and an overview of current U.S.preparedness planning, with an emphasis on the roles of healthcare professionals, are alsoincluded.

^* Corresponding author. Mailing address: Microbiology, GRB526, Massachusetts General Hospital, Fruit St., Boston, MA 02114.Phone: (617) 726-3611. Fax: (617) 726-5957. E-mail: kruoff{at}partners.org,ruoff{at}helix.mgh.harvard.edu.

This article has been cited by other articles:

Moore, S., Mawji, A., Shiell, A., Noseworthy, T. (2007). Public health preparedness: a systems-level approach. J. Epidemiol. Community Health 61: 282-286 [Abstract] [Full Text]
Myers, G. S.A., Rasko, D. A., Cheung, J. K., Ravel, J., Seshadri, R., DeBoy, R. T., Ren, Q., Varga, J., Awad, M. M., Brinkac, L. M., Daugherty, S. C., Haft, D. H., Dodson, R. J., Madupu, R., Nelson, W. C., Rosovitz, M.J., Sullivan, S. A., Khouri, H., Dimitrov, G. I., Watkins, K. L., Mulligan, S., Benton, J., Radune, D., Fisher, D. J., Atkins, H. S., Hiscox, T., Jost, B. H., Billington, S. J., Songer, J. G., McClane, B. A., Titball, R. W., Rood, J. I., Melville, S. B., Paulsen, I. T. (2006). Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res 16: 1031-1040 [Abstract] [Full Text]
Christensen, D. R., Hartman, L. J., Loveless, B. M., Frye, M. S., Shipley, M. A., Bridge, D. L., Richards, M. J., Kaplan, R. S., Garrison, J., Baldwin, C. D., Kulesh, D. A., Norwood, D. A. (2006). Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the LightCycler, and the Smart Cycler Platforms. Clin. Chem. 52: 141-145 [Abstract] [Full Text]
Lim, D. V., Simpson, J. M., Kearns, E. A., Kramer, M. F. (2005). Current and Developing Technologies for Monitoring Agents of Bioterrorism and Biowarfare. Clin. Microbiol. Rev. 18: 583-607 [Abstract] [Full Text]
Panning, M., Asper, M., Kramme, S., Schmitz, H., Drosten, C. (2004). Rapid Detection and Differentiation of Human Pathogenic Orthopox Viruses by a Fluorescence Resonance Energy Transfer Real-Time PCR Assay. Clin. Chem. 50: 702-708 [Abstract] [Full Text]
Scaramozzino, N., Sanz, G., Crance, J. M., Saparbaev, M., Drillien, R., Laval, J., Kavli, B., Garin, D. (2003). Characterisation of the substrate specificity of homogeneous vaccinia virus uracil-DNA glycosylase. Nucleic Acids Res 31: 4950-4957 [Abstract] [Full Text]
Snyder, J. W. (2003). Role of the Hospital-Based Microbiology Laboratory in Preparation for and Response to a Bioterrorism Event. J. Clin. Microbiol. 41: 1-4 [Full Text]
Martinez, J. L., Baquero, F. (2002). Interactions among Strategies Associated with Bacterial Infection: Pathogenicity, Epidemicity, and Antibiotic Resistance. Clin. Microbiol. Rev. 15: 647-679 [Abstract] [Full Text]
Bell, C. A., Uhl, J. R., Hadfield, T. L., David, J. C., Meyer, R. F., Smith, T. F., Cockerill III, F. R. (2002). Detection of Bacillus anthracis DNA by LightCycler PCR. J. Clin. Microbiol. 40: 2897-2902 [Abstract] [Full Text]
Kiratisin, P., Fukuda, C. D., Wong, A., Stock, F., Preuss, J. C., Ediger, L., Brahmbhatt, T. N., Fischer, S. H., Fedorko, D. P., Witebsky, F. G., Gill, V. J. (2002). Large-Scale Screening of Nasal Swabs for Bacillus anthracis: Descriptive Summary and Discussion of the National Institutes of Health's Experience. J. Clin. Microbiol. 40: 3012-3016 [Abstract] [Full Text]
Mohammed, M. J., Marston, C. K., Popovic, T., Weyant, R. S., Tenover, F. C. (2002). Antimicrobial Susceptibility Testing of Bacillus anthracis: Comparison of Results Obtained by Using the National Committee for Clinical Laboratory Standards Broth Microdilution Reference and Etest Agar Gradient Diffusion Methods. J. Clin. Microbiol. 40: 1902-1907 [Abstract] [Full Text]

Antimicrob. Agents Chemother.	Clin. Vaccine Immunol.
J. Clin. Microbiol.	ALL ASM JOURNALS